# Coeptis Therapeutics Holdings Inc. (COEP)

Source: https://www.quantisnow.com/company/COEP
Generated: 2026-11-18T22:28:33.181Z

- Ticker: COEP
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2020
- SEC CIK: 0001759186

## Latest COEP news and filings

- 2026-10-05 21:02 UTC [SEC Form 4] [SEC Form 4 filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-coeptis-therapeutics-holdings-inc-6737378)
- 2026-10-02 23:50 UTC [SEC Form 4] [Chief Executive Officer Halabu David Elias converted options into 19,737 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-halabu-david-elias-converted-options-into-19737-6735630)
- 2026-10-02 23:34 UTC [SEC Form 4] [Director Sohn Adam Craig converted options into 1,370 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-sohn-adam-craig-converted-options-into-1370-shares-sec-6735613)
- 2026-10-02 23:30 UTC [SEC Form 4] [Director Fuerst Bryan Eric converted options into 1,370 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-fuerst-bryan-eric-converted-options-into-1370-shares-sec-6735609)
- 2026-10-02 23:29 UTC [SEC Form 4] [Director Cooper Kenneth Lyle converted options into 1,370 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-cooper-kenneth-lyle-converted-options-into-1370-shares-sec-6735606)
- 2026-10-02 23:15 UTC [SEC Form 4] [Chief Technology Officer Harris Jeffery Keeslar converted options into 12,444 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-technology-officer-harris-jeffery-keeslar-converted-options-into-12444-6735596)
- 2026-10-02 23:06 UTC [SEC Form 4] [Chief Financial Officer Cogley Brian converted options into 4,112 shares, increasing direct ownership by 18% to 26,612 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-cogley-brian-converted-options-into-4112-shares-6735575)
- 2026-10-02 22:49 UTC [Insider Buy] [Amendment: Chief Marketing Officer Schadel Christopher Ryan bought $3,920 worth of shares (1,000 units at $3.92) and converted options into 3,169 shares (SEC Form 4)](https://www.quantisnow.com/insight/amendment-chief-marketing-officer-schadel-christopher-ryan-bought-3920-worth-6735548)
- 2026-09-14 21:01 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-entry-into-6714820)
- 2026-09-10 21:27 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-amendments-to-6712102)
- 2026-08-26 20:30 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-leadership-update-6695786)
- 2026-08-25 22:56 UTC [SEC Form 4] [SEC Form 4 filed by Chief Technology Officer Harris Jeffery Keeslar](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-technology-officer-harris-jeffery-6694707)
- 2026-08-21 20:30 UTC [SEC Form S-8] [SEC Form S-8 filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-coeptis-therapeutics-holdings-inc-6691481)
- 2026-08-20 10:01 UTC [Insider Buy] [Chief Marketing Officer Schadel Christopher Ryan bought $3,920 worth of shares (1,000 units at $3.92) (SEC Form 4)](https://www.quantisnow.com/insight/chief-marketing-officer-schadel-christopher-ryan-bought-3920-worth-of-6689244)
- 2026-08-13 21:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-coeptis-therapeutics-holdings-inc-6681162)
- 2026-08-04 21:29 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-entry-into-6663213)
- 2026-07-27 21:12 UTC [SEC Form POSASR filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-coeptis-therapeutics-holdings-inc-6650123)
- 2026-07-22 21:30 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-termination-of-6645759)
- 2026-07-10 20:00 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-entry-into-6634019)
- 2026-07-07 21:08 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-entry-into-6630418)
- 2026-07-07 13:16 UTC [SEC Form 3] [SEC Form 3 filed by new insider Harris Jeffery Keeslar](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-harris-jeffery-keeslar-6629765)
- 2026-06-30 21:20 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-leadership-update-6621301)
- 2026-06-29 21:19 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-regulation-fd-6619419)
- 2026-06-26 20:30 UTC [SEC Form S-1] [SEC Form S-1 filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-coeptis-therapeutics-holdings-inc-6617550)
- 2026-06-25 22:57 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-entry-into-6616572)
- 2026-06-23 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-coeptis-therapeutics-holdings-inc-6611681)
- 2026-06-18 14:10 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-coeptis-therapeutics-holdings-inc-6608215)
- 2026-06-17 04:16 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-coeptis-therapeutics-holdings-inc-6605742)
- 2026-06-16 10:05 UTC [SEC Form POS AM filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-coeptis-therapeutics-holdings-inc-6603747)
- 2026-06-09 21:59 UTC [SEC Form S-1] [SEC Form S-1 filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-coeptis-therapeutics-holdings-inc-6595952)
- 2026-06-08 20:01 UTC [SEC Form 4] [SEC Form 4 filed by Chief Marketing Officer Schadel Christopher Ryan](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-marketing-officer-schadel-christopher-6593214)
- 2026-06-04 20:02 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-entry-into-6589188)
- 2026-06-01 20:30 UTC [SEC Form 8-K] [Amendment: Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-financial-6582014)
- 2026-05-22 21:00 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-leadership-update-6570389)
- 2026-05-20 23:56 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-regulation-fd-6566161)
- 2026-05-15 13:11 UTC [SEC Form 4] [Large owner Bsg Series Cm, Llc disposed of 41,521,276 shares, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-bsg-series-cm-llc-disposed-of-41521276-shares-6556116)
- 2026-05-15 13:09 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Coeptis Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-coeptis-therapeutics-holdings-6556114)
- 2026-05-05 00:05 UTC [SEC Form 3] [New insider Bsg Series Cm, Llc claimed ownership of 41,521,276 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-bsg-series-cm-llc-claimed-ownership-of-41521276-6530186)
- 2026-05-01 21:21 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-entry-into-6527476)
- 2026-04-30 21:19 UTC [SEC Form 8-K] [Coeptis Therapeutics Holdings Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/coeptis-therapeutics-holdings-inc-filed-sec-form-8-k-completion-of-6525488)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/COEP
- Earnings history: https://www.quantisnow.com/earnings/COEP
- Dividend history: https://www.quantisnow.com/dividends/COEP
- Insider transactions: https://www.quantisnow.com/insiders/COEP
- Options chain: https://www.quantisnow.com/options/COEP
- SEC 8-K filings only: https://www.quantisnow.com/company/COEP/8-k
- RSS and alerts for COEP: https://www.quantisnow.com/docs/rss-feeds.md
